Literature DB >> 12177216

Compromised hemodynamic response in amyloid precursor protein transgenic mice.

Thomas Mueggler1, Christine Sturchler-Pierrat, Diana Baumann, Martin Rausch, Matthias Staufenbiel, Markus Rudin.   

Abstract

APP23 transgenic mice overexpressing amyloid precursor protein (APP751) reproduce neuropathological changes associated with Alzheimer's disease such as high levels of amyloid plaques, cerebral amyloid angiopathy, and associated vascular pathologies. Functional magnetic resonance imaging (fMRI) was applied to characterize brain functionality in these mice through global pharmacological stimulation. The cerebral hemodynamic response to infusion of the GABA(A) antagonist bicuculline was significantly reduced in aged APP23 mice compared with age-matched wild-type littermates. This is in part attributable to a compromised cerebrovascular reactivity, as revealed by the reduced responsiveness to vasodilatory stimulation by acetazolamide. The study shows that fMRI is a sensitive tool to phenotype genetically engineered animals modeling neuropathologies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177216      PMCID: PMC6757895          DOI: 20026680

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice.

Authors:  A L Phinney; T Deller; M Stalder; M E Calhoun; M Frotscher; B Sommer; M Staufenbiel; M Jucker
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers.

Authors:  K R Thulborn; C Martin; J T Voyvodic
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

3.  MRI of entorhinal cortex in mild Alzheimer's disease.

Authors:  M Bobinski; M J de Leon; A Convit; S De Santi; J Wegiel; C Y Tarshish; L A Saint Louis; H M Wisniewski
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

4.  Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report.

Authors:  T A Sandson; M O'Connor; R A Sperling; R R Edelman; S Warach
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

5.  The dose-response relationship of acetazolamide on the cerebral blood flow in normal subjects.

Authors:  W M Grossmann; B Koeberle
Journal:  Cerebrovasc Dis       Date:  2000 Jan-Feb       Impact factor: 2.762

6.  Acetylcholinesterase fibers and the development of senile plaques.

Authors:  H Tago; P L McGeer; E G McGeer
Journal:  Brain Res       Date:  1987-03-17       Impact factor: 3.252

7.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

Authors:  M E Calhoun; P Burgermeister; A L Phinney; M Stalder; M Tolnay; K H Wiederhold; D Abramowski; C Sturchler-Pierrat; B Sommer; M Staufenbiel; M Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

8.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein.

Authors:  C Iadecola; F Zhang; K Niwa; C Eckman; S K Turner; E Fischer; S Younkin; D R Borchelt; K K Hsiao; G A Carlson
Journal:  Nat Neurosci       Date:  1999-02       Impact factor: 24.884

9.  Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study.

Authors:  N Hirono; H Kitagaki; H Kazui; M Hashimoto; E Mori
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

Review 10.  From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy.

Authors:  L de Toledo-Morrell; I Goncharova; B Dickerson; R S Wilson; D A Bennett
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

View more
  25 in total

Review 1.  Imaging Alzheimer's disease.

Authors:  Scott A Small
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

2.  Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging.

Authors:  Scott A Small; Monica K Chawla; Michael Buonocore; Peter R Rapp; Carol A Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 3.  Combining brain imaging with microarray: isolating molecules underlying the physiologic disorders of the brain.

Authors:  Aimee Pierce; Scott A Small
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

4.  Medial temporal lobe function and structure in mild cognitive impairment.

Authors:  Bradford C Dickerson; David H Salat; Julianna F Bates; Monika Atiya; Ronald J Killiany; Douglas N Greve; Anders M Dale; Chantal E Stern; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

Review 5.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 7.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

8.  Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions.

Authors:  Markus Rudin
Journal:  Eur Radiol       Date:  2007-03-06       Impact factor: 5.315

9.  Impaired visual evoked flow velocity response in cerebral amyloid angiopathy.

Authors:  E E Smith; M Vijayappa; F Lima; P Delgado; L Wendell; J Rosand; S M Greenberg
Journal:  Neurology       Date:  2008-10-28       Impact factor: 9.910

Review 10.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies.

Authors:  Bradford C Dickerson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2007-12-08       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.